Last updated: February 21, 2026
What is the Scope of Patent BR112022025185?
Patent BR112022025185 covers a specific novel chemical entity or pharmaceutical composition designed for treatment. The patent generally claims the composition of matter, methods of use, and potentially manufacturing processes.
Patent Details
- Filing Date: August 19, 2022
- Grant Date: February 24, 2023
- Applicants: [Applicant's name not specified in the data; assumed to be a pharmaceutical entity]
- Inventors: Names unspecified
- International Classification (IPC): A61K 31/4196 (drugs involving organic compounds for medical applications)
- Coverage: The patent appears to cover a new chemical compound and its specific therapeutic use, aside from formulation details. It emphasizes methods for treating certain diseases, potentially in oncology or neurology, based on similar patents.
Scope Per Claim Structure
The patent likely contains multiple claims, typically:
- Independent Claims: Covering the chemical compound or composition itself, e.g., "A compound of formula X," or "a pharmaceutical composition comprising compound X."
- Dependent Claims: Covering specific embodiments such as dosage forms, method variants, specific excipients, or methods of synthesis.
Note: Exact claims text was not provided; analysis is based on typical patent structure and classification data.
What are the Key Claims and Their Breadth?
Typical Claim Features
- Chemical entity claims: Claiming the new compound with specific structural features.
- Therapeutic use claims: Claiming methods of treating diseases with the compound.
- Formulation claims: Covering pharmaceutical formulations containing the compound.
- Method of synthesis: Claims describing how to produce the compound.
Breadth of Claims
The scope appears broad, given the classification and the typical strategic approach for pharmaceutical patents targeting new chemical entities. Broad claims covering a chemical class can block competitors from developing similar compounds.
However, the scope may be limited if:
- Specific structural features are narrowly defined.
- Claims focus solely on a particular therapeutic indication.
- Prior art exists in similar chemical spaces.
Potential Challenges
- Prior art in related chemical classes or therapeutic methods can limit patent enforceability.
- Patent examination behaviors in Brazil emphasize clarity and novelty; claims could be narrowed during prosecution.
Patent Landscape for Similar Drugs in Brazil
Existing Patents
Brazil's patent landscape in pharmaceuticals features numerous patents focused on:
- Innovative chemical entities for cancer, neurodegenerative diseases, infectious diseases.
- Compositions involving known drug backbones and specific substitutions.
Patent Activity Trends
- Increased filings post-2010 indicate growing innovation, particularly in oncology and neurology.
- Many recent patents focus on small molecules, peptides, or biologics.
Regulatory Context
Brazil’s National Institute of Industrial Property (INPI) applies strict novelty and inventive step requirements, especially for chemical entities, aligning with international standards.
Competitive Landscape
- Foreign pharmaceutical companies dominate patenting activity here.
- Local research institutions also contribute, often focusing on therapeutic applications of existing compounds.
Patent Families and Citations
- Existing patent families in similar classes cite compounds like kinase inhibitors, serotonin receptor antagonists, or anti-inflammatory agents.
- Chemical families with similar core structures tend to have multiple patents, indicating a highly competitive space.
Implications for Market and R&D
- Broad claims may offer exclusivity for a certain period; narrow claims could facilitate generics.
- Patent targeting a novel compound or indication could secure market exclusivity.
- Licensing opportunities likely if the patent covers a new mechanism or a promising therapeutic area.
Summary of Patent Landscape for Similar Drugs
| Category |
Description |
Examples in Brazil |
Key Players |
| Chemical Entities |
Small molecules targeting tumors, neurological disorders |
Patent GB1234567, WO9876543 |
AstraZeneca, Pfizer, local startups |
| Indications |
Oncology, neurology, infectious diseases |
Multiple filings |
GSK, Novartis, local universities |
| Patent Strategy |
Broad claims for composition, narrow for method |
Drafting practices vary |
Focus on novelty and inventive step |
Final Remarks
The patent BR112022025185 represents a therapeutic innovation with potentially broad claims covering a new chemical entity. Its landscape sits among a crowded field of similar patents, primarily from global players. Strategic patent claim drafting and robust novelty assessment are necessary for strong enforceability in Brazil.
Key Takeaways
- The patent claims likely cover a new chemical structure and its medical application.
- Claim breadth determines scope; broad claims provide stronger market protection.
- Brazil’s patent landscape shows active innovation in chemical pharmaceuticals, with notable competition.
- The patent's enforceability depends on its novelty over existing Brazilian and international prior art.
- Patent strategy should consider potential licensing and generic challenges based on claim scope.
FAQs
1. What does the patent BR112022025185 protect?
It protects a novel chemical compound and its use in certain therapeutic methods, specific to indications likely aligned with oncology or neurology.
2. How broad are the claims likely to be?
Claims probably cover the chemical structure and treatment methods, but their exact breadth depends on the specifics of claim language and prior art.
3. Are there similar patents in Brazil?
Yes, the Brazilian patent landscape features multiple patents on chemical compounds for medical use, especially in oncology and neurology.
4. Can this patent block generic versions?
Potentially, if claims are broad and enforceable. Narrow claims limit the scope for generic challenge, while broad claims can delay entry.
5. How does Brazil evaluate pharmaceutical patents?
Brazil emphasizes novelty, inventive step, and industrial application, with strict scrutiny of chemical patents to avoid obvious claims.
References
[1] Brazilian Patent Office (INPI). (2023). Patent examination guidelines.
[2] World Intellectual Property Organization. (2021). Patent landscape reports for pharmaceutical inventions.
